On 4 to 5 June, ADIS project partners met in Regensburg (Germany) and online for their biannual General Assembly, hosted by the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM-R). The meeting began with opening remarks by the project coordinator Holger Fröhlich Fraunhofer Institute for Algorithms and Scientific Computing (SCAI). Next, Vanessa Lage-Rupprecht (SCAI) reported...Read More
On 16 and 17 May partners from Fraunhofer SCAI presented the ADIS (and COMMUTE) project to the public at a booth. Everybody who was interested could get and introduction to the project and ask questions around the topic. They also gave an intro to school classes and exchanged a bit on the topic “AI in...Read More
Alzheimer’s disease has an increasing prevalence in the population world-wide, yet current diagnostic methods based on recommended biomarkers are only available in specialized clinics. Due to these circumstances, Alzheimer’s disease is usually diagnosed late, which contrasts with the currently available treatment options that are only effective for patients at an early stage. Blood-based biomarkers could...Read More
On 7, 14 and 15 March, the members of the newly set up ADIS Young Adults Advisory Board (ADIS YA-AB) gathered online. These three sessions were also attended by Jesús Rodrigo (Confederación Española de Alzheimer, CEAFA) and David Bartrés-Faz (Universidad de Barcelona), and facilitated by Soraya Moradi-Bachiller (Public Involvement Officer at Alzheimer Europe, AE). During...Read More
The ADIS project is dedicated to advancing early diagnosis of Alzheimer’s disease through immune profiling and sleep disturbance analysis and we’re happy to announce the release of its second newsletter. This edition offers insights into our collaborative research, featuring highlights from early-career researchers, updates from our latest General Assembly, and upcoming events. We invite professionals,...Read More
On 27 February, members of the ADIS Advisory Board gathered online. The meeting was also attended by Andrea del Val (Hospital Clínic de Barcelona) and Ainhoa Etayo (Confederación Española de Alzheimer, CEAFA), and facilitated by Soraya Moradi-Bachiller (Public Involvement Officer at Alzheimer Europe). During the consultation, members of the ADIS Advisory Board and their supporters...Read More
In November 2023, at the first event of its kind, six European research projects joined together in a series of consultations focusing on Public Involvement in dementia and brain health research, organised by Alzheimer Europe. At this event, 44 members of the Advisory Boards of six EU-funded projects (EU-FINGERS, LETHE, Multi-MeMo, eBRAIN-Health, EPND and ADIS),...Read More
From 17 to 18 January (Barcelona, Spain and online), partners from the ADIS project met for their biannual General Assembly meeting. The “Early Diagnosis of Alzheimer’s Disease by Immune Profiling of Cytotoxic Lymphocytes and Recording of Sleep Disturbances” – short ADIS project – is a JPND-funded 1.3 million EUR three-year project, coordinated by Fraunhofer SCAI....Read More
On 12 December, the members of the ADIS Advisory Board (ADIS AB) participated in a social gathering before the end of the year. During the meeting, Alzheimer Europe Public Involvement Officer Soraya Moradi-Bachiller shared an overview of the activities organised with the ADIS AB in 2023 and how the feedback provided by the members was...Read More
Between 14 and 16 November, over 40 members of the Advisory Boards of six EU-funded dementia research projects collaborated in a series of multi-project consultations. These Advisory Boards are composed of people affected by dementia: people living with different types of dementia, individuals who are at risk of dementia or interested in brain health, and...Read More
